CA2000348A1 - Tamper proof encapsulated medicaments - Google Patents
Tamper proof encapsulated medicamentsInfo
- Publication number
- CA2000348A1 CA2000348A1 CA 2000348 CA2000348A CA2000348A1 CA 2000348 A1 CA2000348 A1 CA 2000348A1 CA 2000348 CA2000348 CA 2000348 CA 2000348 A CA2000348 A CA 2000348A CA 2000348 A1 CA2000348 A1 CA 2000348A1
- Authority
- CA
- Canada
- Prior art keywords
- capsule
- caplet
- dosage form
- tamper
- adhesive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
ABSTRACT
A tamper-proof capsule dosage form for pharmaceuticals having a medicinal containing caplet adhesively bonded to the inner end surfaces of the capsule such that upon tampering the capsule dosage form will be destroyed or rendered non-reusable.
A tamper-proof capsule dosage form for pharmaceuticals having a medicinal containing caplet adhesively bonded to the inner end surfaces of the capsule such that upon tampering the capsule dosage form will be destroyed or rendered non-reusable.
Description
A~P-8840 ,:
TAMPER PROOF ENCAPSULATED MEDICAM~NTS
Background Of The Invention This invention related to a tamperproof capsule dosage form for pharmaceutical preparations and more part;cularly to a hard gelatin eapsule dosage form which will be destroyed if opened so that extraneous substances cannot be inserted in the opened capsule and the capsule then re-closed.
The art is replete with systems for loclcing capsules containing pharmaceutical preparations for oral administration. For example, sound waves have been used to lock together the two pieces of hard gelatin shell after the medicament has been enclosed within the capsule formed from the shells. In another system, the larger half of the two-piece capsule fits almost completely over the smaller half. In still another system, a gelatin band is applied to thefilled capsule and fused to hold the two capsule pieces together. Such systems have been found to be lacking in adequate protection, however, since one or several capsules can be opened and the components used to encapsulate an : extraneous substance in capsule components closely resembling the original medication.
mmar~ Of The ~vention This invention comprises a tamper-proof capsule dosage form containing a pharmaceutical medicament for oral administration which will be destroyed ii opened prior to administrQtion. The temper-prooi oapsule dosege ~.:
``:
;
TAMPER PROOF ENCAPSULATED MEDICAM~NTS
Background Of The Invention This invention related to a tamperproof capsule dosage form for pharmaceutical preparations and more part;cularly to a hard gelatin eapsule dosage form which will be destroyed if opened so that extraneous substances cannot be inserted in the opened capsule and the capsule then re-closed.
The art is replete with systems for loclcing capsules containing pharmaceutical preparations for oral administration. For example, sound waves have been used to lock together the two pieces of hard gelatin shell after the medicament has been enclosed within the capsule formed from the shells. In another system, the larger half of the two-piece capsule fits almost completely over the smaller half. In still another system, a gelatin band is applied to thefilled capsule and fused to hold the two capsule pieces together. Such systems have been found to be lacking in adequate protection, however, since one or several capsules can be opened and the components used to encapsulate an : extraneous substance in capsule components closely resembling the original medication.
mmar~ Of The ~vention This invention comprises a tamper-proof capsule dosage form containing a pharmaceutical medicament for oral administration which will be destroyed ii opened prior to administrQtion. The temper-prooi oapsule dosege ~.:
``:
;
2()~ a~
_~_ :
form comprises three basic components including a hard gelatin capsule, a pharmaceutical medicament in caplet, i.e. elongated tablet shape, and an edible adhesive, which components, when assembled hold each end of the caplet adhesively bonded to the adjacent inside surface of the capsule.
Detailed Description Of lhe ~rention The three basic components of the tamper-proof capsule dosage form of the invention comprise:
` a) a hard gelatin capsule, well known in the art, such is marketed by R.P. Seherer Corporation of Troy, New York, made in two pieces in whieh the medicament, usually in powder or particlllate form, is placed in a first piece and the other piece is then slip-fitted over and joined to the first piece;
b) a medicinal caplet for oral administration shaped and sized closely to fit within the assembled capsule; and ;
` c) a pharmaceutically acceptable edible adhesive, the adhesive bonding each end portion of the caplet to the adjacent inside surface of the - capsule.
The hard gelatin capsule can be any size from 4 to 000 and preferably it ` should be a clear gelatin so the user can see the caplet inside and also extraneous `` material, if any.
:.
4~
A~IP-8840 The caplet can contain any of the many medicinals presently marketed over-the-counter or on a prescription basis such as aspirin, acetaminophen and ibuprofen.
The edible adhesive can be a pharmaceutically acceptable water or organic solvent soluble adhesive including a protein adhesive such as zein or casein, a silieone adhesive, a plastic adhesive such as an acrylic polymer, shellac or a cellulose. Also the adhesive can be a heat-sealable or an ultrasound-sealable adhesive well known to the art.
The invention will now be described with reference to the accompanying drawings whereino ; Figure 1 is an exploded view of the tamper-proof encapsulated dosage form of the invention:
, Figure 2 is a view of the assembled tamper-proof encapsulated dosage form of the invention.
Figure 3 is a cross-sectional view along line 3-3, i.e. the elongated axis of the tamper-proof encapsulated dosage Iorm of the invention; and ;~ Figure 4 is a cross-sectional view along line 4-4, i.e. around the ~. circumference of the encapsulated dosage form of the invention.
~ . ~
.:
, .
. .
. ~ ~
~ ' ~
A~{P-8840 Turning now to ~igures 1 through ~, the caplet 1 is sized closely to fit into the capsule designated by its two components 2 and 3. The caplet mold can be designed to provide sufficient tolerance sueh that there is sufficient space at each end 4 and 5 of the caplet 1 and between the inside surfaces 6 and 7 of the capsule ends 2 and 3 to receive a drop or two of adhesive designated 8 and 9 respectively.
The tamper-proof dosage form is assembled by placing the adhesive on each end of the caplet or on the inner end surfaces of the capsule sections, inserting the caplet into the section of the capsule smaller in diameter, then slipping the section of the capsule larger in diameter over the exposed end of the caplet and slip-fitting the two sections together to form the capsule.
.
- Any moisture or solvent in the adhesive will pass through the capsule wall since the gelatin acts as a semi-permeable membrane. If too much moisture is present in the adhesive, the capsule may become deformed, and hence it is preferable to use low moisture content adhesives. Gentle warming of the filled capsules will accelerate the drying of the adhesive.
_~_ :
form comprises three basic components including a hard gelatin capsule, a pharmaceutical medicament in caplet, i.e. elongated tablet shape, and an edible adhesive, which components, when assembled hold each end of the caplet adhesively bonded to the adjacent inside surface of the capsule.
Detailed Description Of lhe ~rention The three basic components of the tamper-proof capsule dosage form of the invention comprise:
` a) a hard gelatin capsule, well known in the art, such is marketed by R.P. Seherer Corporation of Troy, New York, made in two pieces in whieh the medicament, usually in powder or particlllate form, is placed in a first piece and the other piece is then slip-fitted over and joined to the first piece;
b) a medicinal caplet for oral administration shaped and sized closely to fit within the assembled capsule; and ;
` c) a pharmaceutically acceptable edible adhesive, the adhesive bonding each end portion of the caplet to the adjacent inside surface of the - capsule.
The hard gelatin capsule can be any size from 4 to 000 and preferably it ` should be a clear gelatin so the user can see the caplet inside and also extraneous `` material, if any.
:.
4~
A~IP-8840 The caplet can contain any of the many medicinals presently marketed over-the-counter or on a prescription basis such as aspirin, acetaminophen and ibuprofen.
The edible adhesive can be a pharmaceutically acceptable water or organic solvent soluble adhesive including a protein adhesive such as zein or casein, a silieone adhesive, a plastic adhesive such as an acrylic polymer, shellac or a cellulose. Also the adhesive can be a heat-sealable or an ultrasound-sealable adhesive well known to the art.
The invention will now be described with reference to the accompanying drawings whereino ; Figure 1 is an exploded view of the tamper-proof encapsulated dosage form of the invention:
, Figure 2 is a view of the assembled tamper-proof encapsulated dosage form of the invention.
Figure 3 is a cross-sectional view along line 3-3, i.e. the elongated axis of the tamper-proof encapsulated dosage Iorm of the invention; and ;~ Figure 4 is a cross-sectional view along line 4-4, i.e. around the ~. circumference of the encapsulated dosage form of the invention.
~ . ~
.:
, .
. .
. ~ ~
~ ' ~
A~{P-8840 Turning now to ~igures 1 through ~, the caplet 1 is sized closely to fit into the capsule designated by its two components 2 and 3. The caplet mold can be designed to provide sufficient tolerance sueh that there is sufficient space at each end 4 and 5 of the caplet 1 and between the inside surfaces 6 and 7 of the capsule ends 2 and 3 to receive a drop or two of adhesive designated 8 and 9 respectively.
The tamper-proof dosage form is assembled by placing the adhesive on each end of the caplet or on the inner end surfaces of the capsule sections, inserting the caplet into the section of the capsule smaller in diameter, then slipping the section of the capsule larger in diameter over the exposed end of the caplet and slip-fitting the two sections together to form the capsule.
.
- Any moisture or solvent in the adhesive will pass through the capsule wall since the gelatin acts as a semi-permeable membrane. If too much moisture is present in the adhesive, the capsule may become deformed, and hence it is preferable to use low moisture content adhesives. Gentle warming of the filled capsules will accelerate the drying of the adhesive.
Claims
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A tamper-proof capsule dosage form containing a pharmaceutical medicament for oral administration comprising:
a) an elongated essentially round hard gelatin capsule made in two sections slip-fit joinable;
b) a solid caplet containing a medicament susbtance shaped and sized closely to fit within the assembled capsule; and c) a pharmaceutically acceptable adhesive situated between each caplet end and the adjacent inner surface of the capsule.
a) an elongated essentially round hard gelatin capsule made in two sections slip-fit joinable;
b) a solid caplet containing a medicament susbtance shaped and sized closely to fit within the assembled capsule; and c) a pharmaceutically acceptable adhesive situated between each caplet end and the adjacent inner surface of the capsule.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA 2000348 CA2000348A1 (en) | 1989-10-10 | 1989-10-10 | Tamper proof encapsulated medicaments |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA 2000348 CA2000348A1 (en) | 1989-10-10 | 1989-10-10 | Tamper proof encapsulated medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2000348A1 true CA2000348A1 (en) | 1991-04-10 |
Family
ID=4143288
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2000348 Abandoned CA2000348A1 (en) | 1989-10-10 | 1989-10-10 | Tamper proof encapsulated medicaments |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2000348A1 (en) |
-
1989
- 1989-10-10 CA CA 2000348 patent/CA2000348A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4928840A (en) | Tamper proof encapsulated medicaments | |
US5464631A (en) | Encapsulated dosage forms | |
US5415868A (en) | Caplets with gelatin cover and process for making same | |
US5009894A (en) | Arrangement for and method of administering a pharmaceutical preparation | |
US5074426A (en) | Dividable capsule | |
CA2193248C (en) | Caplet and gelatin covering therefor | |
TWI236915B (en) | Capsule with multi-component multi-unit dosage compartments and process for making same | |
US5456919A (en) | Capsule and caplet combination | |
US5460824A (en) | Method for the preparation of an encapsulated medicament | |
AR243375A1 (en) | A completely coated gelatine capsule for pharmaceutical purposes. the procedure and apparatus. | |
GR900100316A (en) | Medicine in a capsule like cover | |
BG49155A3 (en) | Capsules for medicinal forms and method for obtaining them | |
PT705204E (en) | SIGNS FOR LIQUID MEDICINES | |
CA2033414A1 (en) | Capsule and caplet combination | |
EP0305506B1 (en) | Package for of administering a pharmaceutical preparation | |
JPS62133960A (en) | Separable capsule and its production | |
CA2588245A1 (en) | Quick dissolve medicament and method of manufacturing | |
CA2000348A1 (en) | Tamper proof encapsulated medicaments | |
CA2147759A1 (en) | Tilidin dihydrogen orthophosphate, method of preparing it and pharmaceutical preparations containing it | |
AU687420B2 (en) | Soft-shelled gelatin encapsulated particles | |
CA1324594C (en) | Arrangement for and method of administering a pharmaceutical preparation | |
CA2117927C (en) | Caplets with gelatin cover and process for making same | |
CA2214923A1 (en) | Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process | |
KR930000119A (en) | New Oral Medicines | |
TH23867A (en) | Capsule type |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |